Ohnuma T - Search Results

1

The influence of tumor cell density on cellular accumulation of doxorubicin or cisplatin in vitro.

Takemura Y, Kobayashi H, Miyachi H, Hayashi K, Sekiguchi S, Ohnuma T. Takemura Y, et al. Among authors: ohnuma t. Cancer Chemother Pharmacol. 1991;27(6):417-22. doi: 10.1007/BF00685154. Cancer Chemother Pharmacol. 1991. PMID: 2013111

2

Variable expression of RFC1 in human leukemia cell lines resistant to antifolates.

Kobayashi H, Takemura Y, Ohnuma T. Kobayashi H, et al. Among authors: ohnuma t. Cancer Lett. 1998 Feb 27;124(2):135-42. doi: 10.1016/s0304-3835(97)00464-3. Cancer Lett. 1998. PMID: 9500202

3

Relationship between tumor cell density and drug concentration and the cytotoxic effects of doxorubicin or vincristine: mechanism of inoculum effects.

Kobayashi H, Takemura Y, Ohnuma T. Kobayashi H, et al. Among authors: ohnuma t. Cancer Chemother Pharmacol. 1992;31(1):6-10. doi: 10.1007/BF00695987. Cancer Chemother Pharmacol. 1992. PMID: 1458560

4

A human leukemia cell line made resistant to two folate analogues, trimetrexate and N10-propargyl-5,8-dideazafolic acid (CB3717).

Takemura Y, Ohnuma T, Miyachi H, Sekiguchi S. Takemura Y, et al. Among authors: ohnuma t. J Cancer Res Clin Oncol. 1991;117(6):519-25. doi: 10.1007/BF01613282. J Cancer Res Clin Oncol. 1991. PMID: 1683871 Free PMC article.

5

Antitumor efficacy of doxorubicin in combination with cisplatin on human lymphoma cells at various cell densities in vitro.

Takemura Y, Ohnuma T, Sekiguchi S. Takemura Y, et al. Among authors: ohnuma t. Keio J Med. 1991 Jun;40(2):78-81. doi: 10.2302/kjm.40.78. Keio J Med. 1991. PMID: 1881027 Free article.

6

Biologic and pharmacologic effects of harringtonine on human leukemia-lymphoma cells.

Takemura Y, Ohnuma T, Chou TC, Okano T, Holland JF. Takemura Y, et al. Among authors: ohnuma t. Cancer Chemother Pharmacol. 1985;14(3):206-10. doi: 10.1007/BF00258117. Cancer Chemother Pharmacol. 1985. PMID: 3995683

7

Vincristine saturation of cellular binding sites and its cytotoxic activity in human lymphoblastic leukemia cells: mechanism of inoculum effect.

Kobayashi H, Takemura Y, Holland JF, Ohnuma T. Kobayashi H, et al. Among authors: ohnuma t. Biochem Pharmacol. 1998 Apr 15;55(8):1229-34. doi: 10.1016/s0006-2952(97)00615-1. Biochem Pharmacol. 1998. PMID: 9719477

8

Retrovirus-mediated transfer of anti-MDR1 hammerhead ribozymes into multidrug-resistant human leukemia cells: screening for effective target sites.

Kobayashi H, Takemura Y, Wang FS, Oka T, Ohnuma T. Kobayashi H, et al. Among authors: ohnuma t. Int J Cancer. 1999 Jun 11;81(6):944-50. doi: 10.1002/(sici)1097-0215(19990611)81:6<944::aid-ijc17>3.0.co;2-y. Int J Cancer. 1999. PMID: 10362143

9

N10-propargyl-5,8-dideazafolic acid (CB3717): inhibitory effects on human leukemia cell lines resistant to methotrexate or trimetrexate.

Takemura Y, Ohnuma T. Takemura Y, et al. Among authors: ohnuma t. Mt Sinai J Med. 1992 Oct;59(5):419-24. Mt Sinai J Med. 1992. PMID: 1435841

10

Reversal of drug sensitivity in multidrug-resistant tumor cells by an MDR1 (PGY1) ribozyme.

Kobayashi H, Dorai T, Holland JF, Ohnuma T. Kobayashi H, et al. Among authors: ohnuma t. Cancer Res. 1994 Mar 1;54(5):1271-5. Cancer Res. 1994. PMID: 8118816

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

503 results

Search Page

Filters